Memantine, Donepezil, or Combination Therapy—What is the best therapy for Alzheimer’s Disease? A Network Meta‐Analysis
Author:
Affiliation:
1. Department of Rehabilitation Medicine Yongchuan HospitalChongqing Medical University Chongqing China
2. Department of Dermatology Yongchuan HospitalChongqing Medical University Chongqing China
Funder
National Natural Science Foundation of China
Natural Science Foundation of Chongqing
Publisher
Wiley
Subject
Behavioral Neuroscience
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/brb3.1831
Reference37 articles.
1. The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
2. 2019 Alzheimer's disease facts and figures
3. Alzheimer'S Association. (2020).2020 Alzheimer's disease facts and figures [published online ahead of print 2020 Mar 10]. Alzheimers Dement. 2020;https://doi.org/10.1002/alz.12068.
4. Current opinion in Alzheimer's disease therapy by nanotechnology-based approaches
5. The Possibility of an Infectious Etiology of Alzheimer Disease
Cited by 55 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Alzheimer's disease current therapies, novel drug delivery systems and future directions for better disease management;Journal of Controlled Release;2024-03
2. Effect of hormone replacement therapy on amyloid beta (Aβ) plaque density in the rhesus macaque amygdala;Frontiers in Aging Neuroscience;2024-01-11
3. Effect of woohwangchungsimwon and donepezil co-treatment on cognitive function and serum metabolic profiles in a scopolamine-induced model of Alzheimer's disease;Journal of Ethnopharmacology;2024-01
4. Fluoroethylnormemantine (FENM) shows synergistic protection in combination with a sigma-1 receptor agonist in a mouse model of Alzheimer's disease;Neuropharmacology;2024-01
5. Blood brain barrier and its significance in drug delivery to brain in Alzheimer disease;Alzheimer's Disease and Advanced Drug Delivery Strategies;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3